Literature DB >> 31132364

LINGO-1 deficiency promotes nerve regeneration through reduction of cell apoptosis, inflammation, and glial scar after spinal cord injury in mice.

Li-Jun Huang1, Ge Li1, Ying Ding2, Jia-Hui Sun1, Ting-Ting Wu3, Wei Zhao1, Yuan-Shan Zeng4.   

Abstract

Leucine-rich repeat and immunoglobulin domain-containing protein 1 (LINGO-1) is a transmembrane protein that negatively regulates neural regeneration in the central nervous system. LINGO-1 expression is up-regulated after central nerve injury, and is accompanied by cell death. Both LINGO-1 and cell death in the injury microenvironment are thought to limit neural regeneration, but the relationship between LINGO-1 and cell death has not been characterized. To investigate whether LINGO-1 deletion improves the spinal cord microenvironment after spinal cord injury (SCI) and contributes to cell survival, we generated LINGO-1 knockout (KO) mice. These mice and wild-type control mice were subjected to spinal cord transection. Fourteen days after spinal cord transection, cell apoptosis, inflammation, glial scar, and growth of nerve fibers were evaluated by immunostaining. The results showed that LINGO-1 KO mice demonstrated a profound reduction in expression of caspase-3, transferase-mediated deoxyuridine triphosphate biotin nick end labeling (TUNEL), ionized calcium binding adapter molecule 1 (IBA1), glial fibrillary acidic protein (GFAP), and chondroitin sulfate proteoglycans (CSPGs) compared to controls. In contrast, expression of neurofilament (NF) at the SCI site in LINGO-1 KO mice was markedly increased compared to that in wild-type mice. These results suggested that LINGO-1 plays a critical role in the injury microenvironment in processes such as cell death, inflammatory response, and glial scar formation. Importantly, LINGO-1 deletion and a positive microenvironment may exert synergistic effects to promote nerve fiber regeneration. Therefore, inhibition of LINGO-1 may be a therapeutic strategy to promote neural regeneration following SCI. Published by Elsevier Inc.

Entities:  

Keywords:  Cell apoptosis; Glial scar; Inflammation; LINGO-1 knockout; Nerve regeneration; Spinal cord injury

Year:  2019        PMID: 31132364     DOI: 10.1016/j.expneurol.2019.112965

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

Review 1.  Remyelination in PNS and CNS: current and upcoming cellular and molecular strategies to treat disabling neuropathies.

Authors:  Sedigheh Momenzadeh; Mohammad-Saeid Jami
Journal:  Mol Biol Rep       Date:  2021-11-03       Impact factor: 2.316

2.  LINGO-1 shRNA protects the brain against ischemia/reperfusion injury by inhibiting the activation of NF-κB and JAK2/STAT3.

Authors:  Jiaying Zhu; Zhu Zhu; Yipin Ren; Yukang Dong; Yaqi Li; Xiulin Yang
Journal:  Hum Cell       Date:  2021-04-08       Impact factor: 4.174

3.  LncRNA Airsci increases the inflammatory response after spinal cord injury in rats through the nuclear factor kappa B signaling pathway.

Authors:  Tao Zhang; Kang Li; Zi-Lu Zhang; Kai Gao; Chao-Liang Lv
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

4.  Cytokine expressions of spinal cord injury treated by neurotropin and nafamostat mesylate.

Authors:  Chao Sun; Bo Li; Huiquan Duan; Bo Tao; Chenxi Zhao; Wenxiang Li; Yilin Pang; Baoyou Fan; Shiqing Feng
Journal:  Ann Transl Med       Date:  2021-03

Review 5.  Advances in Regeneration of Retinal Ganglion Cells and Optic Nerves.

Authors:  Fa Yuan; Mingwei Wang; Kangxin Jin; Mengqing Xiang
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

6.  ANGPTL8 promotes adipogenic differentiation of mesenchymal stem cells: potential role in ectopic lipid deposition.

Authors:  Jian Tang; Shinan Ma; Yujiu Gao; Fan Zeng; Ying Feng; Chong Guo; Lin Hu; Lingling Yang; Yanghui Chen; Qiufang Zhang; Yahong Yuan; Xingrong Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.